CTLA4 and rheumatoid arthritis: Clinically, the CTLA-4 axis already translates abatacept and demonstrates signal-2 dampening in RA and at-risk states, while structural/trafficking data on CTLA-4 reinforce how ligand competition and surface cycling underwrite this effect.